AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimipin M 2mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Pinarc Life Sciences

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimipin M 2mg/1000mg Tablet ER

Diabexe Duo 2mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation, suitable for adult patients with type 2 diabetes, effectively manages blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. To mitigate this risk, maintain regular eating habits and carry a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical assessment. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Glimipin M 2mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimipin M 2mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimipin M 2mg/1000mg Extended-Release tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glimipin M 2mg/1000mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimipin M 2mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimipin M 2mg/1000mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with food.

How Glimipin M 2mg/1000mg Tablet ER works:

Glimepiride/Metformin Extended-Release tablets (2mg/1000mg) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimipin M 2mg/1000mg Tablet ER with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimipin M tablets (2mg/1000mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimipin M tablets (2mg/1000mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimipin M 2mg/1000mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Glimipin M 2mg/1000mg Extended-Release tablets cautiously. Dosage modification of Glimipin M 2mg/1000mg Extended-Release tablets may be necessary. Medical advice is recommended. For those with mild to moderate liver disease, Glimipin M 2mg/1000mg Extended-Release tablets are typically initiated at a low dose; however, their use is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Glimipin M 2mg/1000mg Tablet ER :

Should you forget to take a Glimipin M 2mg/1000mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimipin M 2mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimipin M 2mg/1000mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimipin M 2mg/1000mg Tablet ER can cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glimipin M 2mg/1000mg Tablet ER and seek immediate medical attention.
Glimipin M 2mg/1000mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimipin M 2mg/1000mg ER tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimipin M 2mg/1000mg ER tablets can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimipin M 2mg/1000mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimipin M 2mg/1000mg ER tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimipin M 2mg/1000mg Tab...
85
MRP 99
13% off